Form 4: Varex Imaging Corp Executive Granted Stock Options and Restricted Stock Units

Karen L. Aranki, Chief Human Resources Officer at Varex Imaging Corp, received stock options and restricted stock units on August 15, 2024.

Summary

• Karen L. Aranki, the Chief Human Resources Officer of Varex Imaging Corp, filed a Form 4 on September 5, 2024, reporting transactions that occurred on August 15, 2024.
• Aranki was granted 7,949 Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
• These RSUs vest 50% on August 15, 2026, and 50% on August 15, 2028, with vested shares delivered upon the vest date.
• Aranki also received 17,094 Non-Qualified Stock Options with an exercise price of $13.84.
• These options vest over a four-year schedule, with 25% vesting on August 15, 2025, and the remainder vesting monthly on a pro rata basis.
• The filing was submitted late due to an inadvertent administrative error.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The equity grants are a positive sign of aligning executive interests with shareholders, but the late filing is a minor negative.

Positives

• The grant of stock options and restricted stock units to a key executive aligns their interests with those of the shareholders.
• The vesting schedules for both the RSUs and stock options encourage long-term commitment from the executive.

Negatives

• The Form 4 filing was submitted late due to an administrative error, which could raise minor concerns about internal controls.

Risks

• The value of the stock options is dependent on the future performance of Varex Imaging Corp's stock price.
• If the stock price does not increase above the exercise price of $13.84, the stock options may not be valuable to the executive.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the equity grants suggest an expectation of continued growth and value creation.

Industry Context

Equity grants are a common practice in the industry to incentivize and retain key executives. The specific terms of the grants (vesting schedule, exercise price) are tailored to the company's specific circumstances and compensation philosophy.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation tools for executives in publicly traded companies, including those in the medical imaging sector.
• Companies like Siemens Healthineers, GE Healthcare, and Philips also utilize similar equity-based compensation plans to align executive incentives with shareholder value.
• Vesting schedules of 2-4 years are typical to ensure long-term commitment.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align executive interests with the company's long-term success.
• Employees may see the grants as a sign of the company's commitment to its leadership team.

Key Dates